Jamie A. Donadio
Nessuna posizione attualmente
Profilo
Jamie A.
Donadio worked as a Senior Director-Finance at Amylin Pharmaceuticals, Inc. from 2001 to 2013.
Prior to that, he worked as a Senior Accountant at Novatel Wireless, Inc. from 1977 to 2000.
From 2013 to 2020, he served as the Chief Financial Officer & Senior Vice President at Mirati Therapeutics, Inc. Donadio received his undergraduate degree from Babson College in 1997.
Precedenti posizioni note di Jamie A. Donadio
| Società | Posizione | Fine |
|---|---|---|
| MIRATI THERAPEUTICS | Direttore Finanziario/CFO | 03/01/2020 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Direttore Finanziario/CFO | 01/01/2013 |
Novatel Wireless, Inc.
 Novatel Wireless, Inc. Specialty TelecommunicationsCommunications Novatel Wireless, Inc. engages in the provision of solutions for the Internet of Things (IoT). It offers communications and analytics for consumers and businesses of industries including vehicle fleet management and telematics, connected retail systems, government, home security, and other connected life scenarios. The company was founded by Horst Julius Pudwill on April 26, 1996 and is headquartered in San Diego, CA. | Comptroller/Controller/Auditor | 01/12/2000 |
Formazione di Jamie A. Donadio
| Babson College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
Novatel Wireless, Inc.
Novatel Wireless, Inc. Specialty TelecommunicationsCommunications Novatel Wireless, Inc. engages in the provision of solutions for the Internet of Things (IoT). It offers communications and analytics for consumers and businesses of industries including vehicle fleet management and telematics, connected retail systems, government, home security, and other connected life scenarios. The company was founded by Horst Julius Pudwill on April 26, 1996 and is headquartered in San Diego, CA. | Communications |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Jamie A. Donadio
